These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 17078926)

  • 1. G protein-coupled receptors in major psychiatric disorders.
    Catapano LA; Manji HK
    Biochim Biophys Acta; 2007 Apr; 1768(4):976-93. PubMed ID: 17078926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.
    Rahman MM; Islam MR; Mim SA; Sultana N; Chellappan DK; Dua K; Kamal MA; Sharma R; Emran TB
    Oxid Med Cell Longev; 2022; 2022():8425640. PubMed ID: 36187336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of G-protein coupled receptor signalling underpinning neurobiology of mood disorders and depression.
    Grammatopoulos DK
    Mol Cell Endocrinol; 2017 Jul; 449():82-89. PubMed ID: 28229904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.
    Boczek T; Mackiewicz J; Sobolczyk M; Wawrzyniak J; Lisek M; Ferenc B; Guo F; Zylinska L
    Cells; 2021 May; 10(5):. PubMed ID: 34067760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions.
    Monfared RV; Alhassen W; Truong TM; Gonzales MAM; Vachirakorntong V; Chen S; Baldi P; Civelli O; Alachkar A
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Concepts and Treatments of Schizophrenia.
    Stępnicki P; Kondej M; Kaczor AA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30127324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A beta-arrestin 2 signaling complex mediates lithium action on behavior.
    Beaulieu JM; Marion S; Rodriguiz RM; Medvedev IO; Sotnikova TD; Ghisi V; Wetsel WC; Lefkowitz RJ; Gainetdinov RR; Caron MG
    Cell; 2008 Jan; 132(1):125-36. PubMed ID: 18191226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk within GPCR heteromers in schizophrenia and Parkinson's disease: physical or just functional?
    Guixa-Gonzalez R; Bruno A; Marti-Solano M; Selent J
    Curr Med Chem; 2012; 19(8):1119-34. PubMed ID: 22300049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders.
    Dean B; Scarr E
    Curr Mol Med; 2015; 15(3):253-64. PubMed ID: 25817858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G Protein-coupled Receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders.
    Sharaf SE
    CNS Neurol Disord Drug Targets; 2024; 23(2):232-245. PubMed ID: 37016522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptors as promising cancer targets.
    Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
    Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.
    Toro C; Deakin JF
    Schizophr Res; 2005 Dec; 80(2-3):323-30. PubMed ID: 16140506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.
    Wang L; Martin B; Brenneman R; Luttrell LM; Maudsley S
    J Pharmacol Exp Ther; 2009 Nov; 331(2):340-8. PubMed ID: 19667132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders.
    Mohite S; Sanches M; Teixeira AL
    Protein Pept Lett; 2020; 27(6):449-455. PubMed ID: 31868144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances of purinergic system in affective disorders and schizophrenia.
    Malewska-Kasprzak MK; Permoda-Osip A; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):577-587. PubMed ID: 31522198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.
    Thompson Ray M; Weickert CS; Wyatt E; Webster MJ
    J Psychiatry Neurosci; 2011 May; 36(3):195-203. PubMed ID: 21223646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCR drug discovery: novel ligands for CNS receptors.
    Lim WK
    Recent Pat CNS Drug Discov; 2007 Jun; 2(2):107-12. PubMed ID: 18221221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway.
    Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
    Transl Psychiatry; 2013 Jun; 3(6):e271. PubMed ID: 23778581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.
    Beneyto M; Kristiansen LV; Oni-Orisan A; McCullumsmith RE; Meador-Woodruff JH
    Neuropsychopharmacology; 2007 Sep; 32(9):1888-902. PubMed ID: 17299517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.